V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20215747 | 20130572 | 1.78 | 94 | Palliative (P) | 2016-05-02 | 2016-07-03 | Oxaliplatin + Raltitrexed | 02 | N | OXALIPLATIN + RALTITREXED | 100207819 |
| 20215749 | 20130573 | 1.63 | 80 | Curative (C) | 2017-02-18 | 2017-02-20 | Trial Unspecified | 02 | N | TRIAL | 100035050 |
| 20215751 | 20130574 | 1.75 | 95.5 | Curative (C) | 2017-09-28 | 2020-11-08 | EOX | N | N | EOX | 100796846 |
| 20215752 | 20130575 | 1.83 | 73 | Palliative (P) | 2018-10-22 | 2018-10-23 | EOX | 02 | Y | CETUXIMAB + IRINOTECAN + MDG | 100754588 |
| 20215753 | 20130576 | 1.78 | 73.4 | Curative (C) | 2019-10-04 | 2019-10-07 | EOX | 02 | Y | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100945170 |
| 20215754 | 20130577 | null | 100.5 | Neo-adjuvant (N) | null | 2021-05-02 | EOX | 02 | N | EOX | 101522245 |
| 20215756 | 20130578 | 1.75 | 89 | Neo-adjuvant (N) | 2018-09-07 | 2018-10-01 | CAPECITABINE + RT | 02 | N | CAPECITABINE + RT | 100675504 |
| 20215757 | 20130579 | null | 62.3 | Curative (C) | 2021-04-04 | 2021-04-04 | EOX | 2 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101776537 |
| 20215758 | 20130580 | 1.62 | 51 | Palliative (P) | 2017-11-07 | 2017-11-07 | Oxaliplatin + Raltitrexed | 02 | N | OXALIPLATIN + RALTITREXED | 100559608 |
| 20215760 | 20130581 | 1.63 | 71.2 | Palliative (P) | 2017-03-21 | 2018-01-18 | Trial Unspecified | 02 | null | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101092492 |
| 20215762 | 20130582 | 1.62 | 46.8 | Palliative (P) | 2016-09-04 | 2016-09-12 | Trial Unspecified | 02 | N | TRIAL | 101290345 |
| 20215763 | 20130583 | 1.74 | 78.7 | null | 2016-12-11 | 2016-12-12 | Sorafenib | 02 | N | SORAFENIB | 101495859 |
| 20215766 | 20130584 | 1.78 | 78 | null | 2021-07-16 | 2021-07-30 | Sorafenib | 02 | null | SORAFENIB | 101115907 |
| 20215767 | 20130585 | 1.71 | 79 | Curative (C) | 2018-06-07 | 2018-06-19 | EOX | 02 | null | SORAFENIB | 100761428 |
| 20215770 | 20130586 | 1.59 | 78.4 | Palliative (P) | 2020-06-22 | 2020-06-22 | Cetuximab + FLUOROURACIL + OXALIPLATIN | 02 | null | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100290113 |
| 20215771 | 20130587 | 1.54 | 57 | Palliative (P) | 2018-09-26 | 2018-10-05 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + IRINOTECAN + MDG | 101361384 |
| 20215774 | 20130588 | 1.84 | 56.25 | Palliative (P) | 2020-01-06 | 2020-01-06 | Sorafenib | 02 | N | SORAFENIB | 100703986 |
| 20215775 | 20130589 | 1.82 | 57.5 | Adjuvant (A) | 2020-01-22 | 2020-01-25 | CAPECITABINE + RT | 02 | N | CAPECITABINE + RT | 101280717 |
| 20215776 | 20130590 | 1.55 | 64.8 | Palliative (P) | 2019-10-03 | 2019-10-14 | EOX | 02 | null | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101590620 |
| 20215778 | 20130591 | 1.7 | 84.75 | null | 2016-11-26 | 2016-12-03 | EOX | N | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100912373 |
| 20215780 | 20130592 | 1.62 | 65.4 | null | 2019-01-07 | 2019-01-09 | EOX | 02 | null | SORAFENIB | 101515440 |
| 20215781 | 20130593 | 1.58 | 90.6 | Palliative (P) | 2016-05-01 | 2016-08-03 | EOX | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101565419 |
| 20215782 | 20130594 | 1.79 | 120.5 | null | 2018-08-13 | 2018-08-13 | CETUXIMAB + IRINOTECAN + MDG | 99 | null | CETUXIMAB + IRINOTECAN + MDG | 100555639 |
| 20215784 | 20130595 | 1.56 | 114 | null | 2015-11-13 | 2015-11-13 | EOX | N | null | CETUXIMAB + IRINOTECAN + MDG | 100778806 |
| 20215785 | 20130596 | 1.66 | 100.5 | null | 2017-02-08 | 2017-02-14 | IRINOTECAN + MDG + PANITUMUMAB | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101034836 |
| 20215786 | 20130597 | 1.67 | 62.6 | Adjuvant (A) | 2020-07-14 | 2020-07-28 | Oxaliplatin + Raltitrexed | 02 | N | OXALIPLATIN + RALTITREXED | 100804692 |
| 20215788 | 20130598 | null | null | Disease modification (D) | 2019-09-05 | 2019-09-13 | CAPECITABINE + RT | 02 | Y | CAPECITABINE + RT | 101832335 |
| 20215790 | 20130599 | 1.71 | 55 | Curative (C) | 2018-06-03 | 2018-06-03 | Trial Unspecified | N | N | EOX | 101796850 |
| 20215791 | 20130600 | 1.51 | 70.6 | null | 2017-02-15 | 2017-02-22 | EOX | 2 | null | CETUXIMAB + IRINOTECAN + MDG | 101194513 |
| 20215794 | 20130601 | 1.71 | 102 | Palliative (P) | 2015-11-25 | 2016-05-14 | EOX | 02 | Y | SORAFENIB | 100733981 |
| 20215795 | 20130602 | 1.78 | 48.2 | Adjuvant (A) | null | 2020-06-25 | EOX | N | N | TRIAL | 101118523 |
| 20215796 | 20130603 | 1.57 | 95.9 | Adjuvant (A) | 2019-11-20 | 2019-11-20 | Sorafenib | 02 | N | SORAFENIB | 100380832 |
| 20215797 | 20130604 | null | null | Palliative (P) | 2016-03-22 | 2016-03-22 | EOX | 02 | N | EOX | 100481215 |
| 20215798 | 20130605 | 1.58 | 68.4 | Palliative (P) | 2016-07-14 | 2016-08-22 | Sorafenib | 02 | N | SORAFENIB | 101399052 |
| 20215799 | 20130606 | 1.6 | 51.7 | Palliative (P) | 2017-03-02 | 2017-06-02 | EOX | 02 | N | EOX | 101218620 |
| 20215801 | 20130607 | 1.79 | 46.8 | null | 2019-07-08 | 2019-07-15 | EOX | N | null | EOX | 100724552 |
| 20215802 | 20130608 | 1.7 | 0 | Neo-adjuvant (N) | 2017-06-12 | 2017-07-10 | IRINOTECAN + MDG + PANITUMUMAB | 01 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100572214 |
| 20215805 | 20130609 | 1.56 | 63.3 | Palliative (P) | 2020-01-29 | 2020-01-29 | Sorafenib | 2 | N | SORAFENIB | 100736414 |
| 20215806 | 20130610 | 1.9 | 88.1 | Neo-adjuvant (N) | 2017-12-07 | 2017-12-12 | EOX | 02 | N | CAPECITABINE + RT | 100857651 |
| 20215807 | 20130611 | 1.6 | 54.2 | Disease modification (D) | 2017-06-12 | 2017-06-30 | Capecitabine 35days + RT | 02 | N | CAPECITABINE + RT | 100663324 |
| 20215808 | 20130612 | 1.69 | 69.4 | Palliative (P) | 2019-10-02 | 2019-10-03 | Sorafenib | 02 | N | SORAFENIB | 100869446 |
| 20215810 | 20130613 | null | null | null | 2019-02-10 | 2019-02-19 | EOX | N | Y | TRIAL | 100943986 |
| 20215811 | 20130614 | 1.64 | 0 | Palliative (P) | 2012-11-15 | 2017-12-23 | Sorafenib | 02 | N | SORAFENIB | 101580733 |
| 20215812 | 20130615 | 1.84 | 80.45 | Palliative (P) | 2018-08-25 | 2018-08-25 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + IRINOTECAN + MDG | 101412970 |
| 20215813 | 20130616 | null | 88.5 | Palliative (P) | 2019-03-21 | 2019-05-02 | EOX | 2 | null | OXALIPLATIN + RALTITREXED | 100361771 |
| 20215814 | 20130617 | 1.74 | 74.5 | Palliative (P) | 2019-10-29 | 2019-11-15 | CAPECITABINE + RT | 2 | N | CAPECITABINE + RT | 101061546 |
| 20215821 | 20130618 | 1.6 | 80 | Neo-adjuvant (N) | 2017-09-25 | 2017-12-21 | Sorafenib | 99 | N | SORAFENIB | 101280153 |
| 20215822 | 20130619 | 1.81 | 56.45 | Palliative (P) | 2018-07-09 | 2018-07-09 | Oxaliplatin + Raltitrexed | 02 | null | OXALIPLATIN + RALTITREXED | 100528737 |
| 20215823 | 20130620 | 1.87 | 0 | Curative (C) | 2018-03-25 | 2018-03-27 | Oxaliplatin + Raltitrexed | 01 | N | OXALIPLATIN + RALTITREXED | 100672881 |
| 20215826 | 20130621 | 1.73 | 73 | null | null | 2018-10-28 | Capecitabine + Mitomycin | 02 | null | CAPECITABINE + MITOMYCIN | 101861939 |